A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone

References

• Tariot PN. The older patient: the ongoing challenge of efficacy and tolerability. J Clin Psychiatry 1999;60:29–33
   PubMed Web of Science ®Google Scholar
• Byerly MJ, Weber MT, Brooks DL, Snow LR, Worley MA, Lescouflair E. Antipsychotic medications and the elderly: effects on cognition and implications for use. Drugs Aging 2001;18:45–61
   PubMed Web of Science ®Google Scholar
• Masand PS. Side effects of antipsychotics in the elderly. J Clin Psychiatry 2000;61:43–9
   PubMed Web of Science ®Google Scholar
• Davidson M, Harvey PD, Vervarcke J, et al. A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group. Int J Geriatr Psychiatry 2000;15:506–14
   PubMed Web of Science ®Google Scholar
• Bullock R, Libretto S. Risperidone in the treatment of psychoses in the elderly: a case report series. Eur Psychiatry 2002;17:96–103
   PubMed Web of Science ®Google Scholar
• Barak Y, Shamir E, Weizman R. Would a switch from typical antipsychotics to risperidone be beneficial for elderly schizophrenic patients? A naturalistic, long-term, retrospective, comparative study. J Clin Psychopharmacol 2002;22:115–20
   Google Scholar
• Rainer MK, Masching AJ, Ertl MG, Kraxberger E, Haushofer M. Effect of risperidone on behavioral and psychological symptoms and cognitive function in dementia. J Clin Psychiatry 2001;62:894–900
   Google Scholar
• Hwang JP, Yang CH, Yu HC, Chang JW, Cheng CY, Tsai SJ. The efficacy and safety of risperidone for the treatment of geriatric psychosis. J Clin Psychopharmacol 2001;21:583–7
   PubMed Web of Science ®Google Scholar
• Garver DL. Review of quetiapine side effects. J Clin Psychiatry 2000;61:31–3
   PubMed Web of Science ®Google Scholar
• McManus DQ, Arvanitis LA, Kowalcyk BB. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group. J Clin Psychiatry 1999;60: 292–8
   Google Scholar
• Tariot P, Salzman C, Yeung P, Pultz P, Rak I. Long-term use of quetiapine in elderly patients with psychotic disorders. Clin Ther 2000;22:1068–84
   Google Scholar
• Arvanitis LA, Miller BG. Multiple fixed doses of ‘Seroquel’ (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Biol Psychiatry 1997;42:233–46
   Google Scholar
• King DJ, Link CG, Kowalcyk B. A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia. Psychopharmacology (Berl) 1998;137:139–46
   Google Scholar
• Kasper S, Muller-Spahn F. Review of quetiapine and its clinical applications in schizophrenia. Expert Opin Pharmacother 2000;1:783–801
   PubMedGoogle Scholar
• Dev V, Raniwalla J. Quetiapine: A review of its safety in the management of schizophrenia. Drug Saf 2000;23:295–307
   PubMed Web of Science ®Google Scholar
• Green B. Focus on quetiapine. Curr Med Res Opin 1999; 15:145–51
   PubMed Web of Science ®Google Scholar
• Fleischhacker WW, Lemmens P, van Baelen B. A qualitative assessment of the neurological safety of antipsychotic drugs; an analysis of a risperidone database. Pharmacopsychiatry 2001;34:104–10
   Google Scholar
• Peuskens J. Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group. Br J Psychiatry 1995;166:712–26
   PubMed Web of Science ®Google Scholar
• Love RC, Nelson MW. Pharmacology and clinical experience with risperidone. Expert Opin Pharmacother 2000;1:1441–53
   PubMedGoogle Scholar
• Jeste DV, Barak Y, Madhusoodanan S, Grossman F, Gharabawi G. International multisite double-blind trial of the atypical anti-psychotics risperidone and olanzapine in 175 elderly patients with chronic schizophrenia. Am J Geriatr Psychiatry 2003;11: 638–47
   Google Scholar
• Harvey PD, Napolitano JA, Mao L, Gharabawi G. Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder. Int J Geriatr Psychiatry 2003;18:820–29
   PubMed Web of Science ®Google Scholar
• Ellingrod VL, Schultz SK, Ekstam-Smith K, Kutscher E, Turvey C, Arndt S. Comparison of risperidone with olanzapine in elderly patients with dementia and psychosis. Pharmacotherapy 2002;22:1–5
   Google Scholar
• Fontaine CS, Hynan LS, Koch K, Martin-Cook K, Svetlik D, Weiner MF. A double-blind comparison of olanzapine versus risperidone in the acute treatment of dementia-related behavioral disturbances in extended care facilities. J Clin Psychiatry 2003;64:726–30
   Google Scholar
• Mullen J, Jibson MD, Sweitzer D. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the Quetiapine Experience With Safety and Tolerability (QUEST) study. Clin Ther 2001;23:1839–54
   Google Scholar
• Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC: American Psychiatric Association, American Psychiatric Press, 1994
   Google Scholar
• Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75:800–2
   Web of Science ®Google Scholar
• Erbagci H, Yildirim H, Herken H, Gumusburun E. A magnetic resonance imaging study of the adhesio interthalamica in schizophrenia. Schizophr Res 2002;55:89–92
   PubMed Web of Science ®Google Scholar
• Maixner SM, Mellow AM, Tandon R. The efficacy, safety, and tolerability of antipsychotics in the elderly. J Clin Psychiatry 1999;60:29–41
   Google Scholar
• Zaleon CR, Guthrie SK. Antipsychotic drug use in older adults. Am J Hosp Pharm 1994;51:2917–43
   PubMedGoogle Scholar